Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Align Technology Inc(ALGN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ALGN
11/02/2026: ALGN (1-star) is currently NOT-A-BUY. Pass it for now.
Align Technology is a specialized medical device company known for its Invisalign clear aligner system and iTero digital scanning tools. The company has a leading position in the orthodontics market, benefiting from a robust digital ecosystem that integrates diagnosis, treatment planning, and manufacturing. Its primary growth opportunity lies in the global shift from traditional metal braces to digital, aesthetic solutions and the expansion of its platform into general dentistry. However, the company faces significant risks from increased competition, economic pressures on elective procedures, and valuation volatility. It may best suit growth-oriented investors, and market observers should monitor doctor adoption trends and global procedure volumes.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Align operates in a large addressable market with high barriers to entry, favoring long-term growth objectives. |
| Momentum investor | Mixed fit | Momentum fit is conditional on the stock demonstrating a clear uptrend in price relative to its moving averages. |
| Value investor | Mixed fit | As a premium medical technology stock, valuation can be high, requiring patience for entry during pullbacks. |
| Dividend investor | Weak fit | Align does not currently offer a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Weak fit | The stock exhibits high beta and volatility, which may not suit conservative capital preservation strategies. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock price is sensitive to growth expectations and global economic health. |
| Valuation risk | Medium / high | Growth expectations are often priced into the stock, leaving little margin for error in earnings reports. |
| Competition risk (Clear aligner market) | Medium / high | New entrants and low-cost competitors put pressure on pricing and market share. |
| Business quality | Strong | Align possesses a powerful brand, high margins, and a sticky customer base of orthodontists. |
| Dividend income | Low / none | No dividend income is provided to shareholders. |
| Execution risk | Medium | Success depends on continuing to train clinicians and innovate in digital dentistry. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -54.68% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 10.65B USD | Price to earnings Ratio 21.85 | 1Y Target Price 186.5 |
Price to earnings Ratio 21.85 | 1Y Target Price 186.5 | ||
Volume (30-day avg) 996.6K shares | Beta 1.67 | 52 Weeks Range 130.23 - 200.44 | Updated Date 11/01/2026 |
52 Weeks Range 130.23 - 200.44 | Updated Date 11/01/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 6.86 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Clear Aligner Sales | Revenue from Invisalign aligners and related treatment planning services. | This is the core revenue engine driven by the number of cases started by orthodontists. |
| Imaging and CAD/CAM | Revenue from the sale and service of iTero scanners and exocad software. | This segment provides technology infrastructure that locks doctors into the Align ecosystem. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-28 | When After Market | Estimate 2.32 | Actual 2.37 |
Profitability
Profit Margin 11.83% | Operating Margin (TTM) 20.13% |
Management Effectiveness
Return on Assets (TTM) 7.93% | Return on Equity (TTM) 11.9% |
Valuation
Trailing PE 21.85 | Forward PE 11.81 | Enterprise Value 9.62B | Price to Sales(TTM) 2.56 |
Enterprise Value 9.62B | Price to Sales(TTM) 2.56 | ||
Enterprise Value to Revenue 2.31 | Enterprise Value to EBITDA 13.41 | Shares Outstanding 71.04M | Shares Floating 66.80M |
Shares Outstanding 71.04M | Shares Floating 66.80M | ||
Percent Insiders 6.13 | Percent Institutions 104.72 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.